Morpholino

MO1-ranbp2

ID

ZDB-MRPHLNO-200124-5

Name

MO1-ranbp2

Previous Names

Target

Sequence

5' - CATGTCTGAAGGAGAAAACACACAC - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

None

Genome Resources

None

Target Location

Genomic Features

No data available

Expression

Gene expression in Wild Types + MO1-ranbp2

Expressed Gene	Anatomy	Figures
ranbp2	whole organism	Fig. 1 from Magre et al., 2019

Phenotype

Phenotype resulting from MO1-ranbp2

Phenotype	Fish	Figures
head hydrocephalic, abnormal	TU + MO1-ranbp2	Fig. 1 from Magre et al., 2019
peridermal cell actin-based cell projection ab1-llgl2 labeling increased amount, abnormal	TU + MO1-ranbp2	Fig. S2 from Magre et al., 2019
peridermal cell actin-based cell projection increased length, abnormal	TU + MO1-ranbp2	Fig. 1, Fig. 2, Fig. S2 from Magre et al., 2019
peridermal cell apical side ab1-llgl2 labeling increased amount, abnormal	TU + MO1-ranbp2	Fig. S2 from Magre et al., 2019
whole organism ranbp2 expression decreased amount, abnormal	TU + MO1-ranbp2	Fig. 1 from Magre et al., 2019
whole organism ab1-prkcz labeling increased amount, abnormal	TU + MO1-ranbp2	Fig. 4 from Magre et al., 2019

Phenotype of all Fish created by or utilizing MO1-ranbp2

Phenotype	Fish	Conditions	Figures
peridermal cell apical side ab1-llgl2 labeling increased amount, abnormal	TU + MO1-ranbp2	control	Fig. S2 from Magre et al., 2019
whole organism ranbp2 expression decreased amount, abnormal	TU + MO1-ranbp2	standard conditions	Fig. 1 from Magre et al., 2019
whole organism ab1-prkcz labeling increased amount, abnormal	TU + MO1-ranbp2	control	Fig. 4 from Magre et al., 2019
peridermal cell actin-based cell projection increased length, abnormal	TU + MO1-ranbp2	standard conditions	Fig. 1, Fig. 2, Fig. S2 from Magre et al., 2019
head hydrocephalic, abnormal	TU + MO1-ranbp2	standard conditions	Fig. 1 from Magre et al., 2019
peridermal cell actin-based cell projection ab1-llgl2 labeling increased amount, abnormal	TU + MO1-ranbp2	control	Fig. S2 from Magre et al., 2019
peridermal cell actin-based cell projection decreased length, abnormal	llgl2^to6/to6 + MO1-ranbp2 (TU)	control	Fig. 2 from Magre et al., 2019
peridermal cell ab1-llgl2 labeling decreased amount, abnormal	llgl2^to6/to6 + MO1-ranbp2 (TU)	control	Fig. 2 from Magre et al., 2019
peridermal cell actin-based cell projection decreased length, abnormal	TU + MO1-llgl1 + MO1-ranbp2	standard conditions	Fig. S2 from Magre et al., 2019

Citations